Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 13,000 shares at $48.47 ($633K) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market sale of $633k RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.47 | 4,647 | $225K | 35.6% |
| 2 | $48.47 | 4,647 | $225K | 35.6% |
| 3 | $49.16 | 1,853 | $91K | 14.4% |
| 4 | $49.16 | 1,853 | $91K | 14.4% |
| Total | $48.67 avg | 13,000 | $633K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |